You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interleukin-9 (IL-9)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Mouth Diseases, Periodontal Inflammation, Periodontal Diseases Trial in Antalya (GCF obtaining, Saliva Obtaining, Serum

Completed
  • Mouth Diseases
  • +2 more
  • GCF obtaining
  • +2 more
  • Antalya, Turkey
    Akdeniz University Faculty of Dentistry
Jun 29, 2022

Hematopoietic Stem Cell Transplantation Trial in Nantes (IL2, Zoledronic Acid)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • IL2
  • Zoledronic Acid
  • Nantes, France
    Nantes Uh
Mar 29, 2022

Interleukin-6 Inhibition, Physical Stress, Appetitive Behavior Trial in Copenhagen Ø (Tocilizumab Injectable Product, Saline

Completed
  • Interleukin-6 Inhibition
  • +2 more
  • Tocilizumab Injectable Product
  • Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour
  • Copenhagen Ø, Denmark
    Center For Physical Activity (CFAS)
Aug 19, 2022

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Completed
  • Metastatic Melanoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

Recruiting
  • Subarachnoid Hemorrhage
  • Plymouth, Devon, United Kingdom
  • +11 more
May 16, 2022

Acute Myeloid Leukemia Trial in Toronto (IL-12)

Recruiting
  • Acute Myeloid Leukemia
  • IL-12
  • Toronto, Ontario, Canada
    Princess Margaret Centre Centre
Apr 16, 2021

Amyotrophic Lateral Sclerosis Trial in France, United Kingdom (Riluzole, IL-2, 5% glucose water solution)

Completed
  • Amyotrophic Lateral Sclerosis
  • Lille, France
  • +16 more
Apr 1, 2022

Neuroblastoma, Osteosarcoma Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Neuroblastoma
  • Osteosarcoma
  • iC9.GD2.CAR.IL-15 T-cells
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jan 4, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

IL-9/E-cadherin and Ferroptosis in Intestinal Mucosal Barrier

Recruiting
  • Sepsis
  • +2 more
  • Standard treatments for sepsis
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Jun 5, 2022

Gastrointestinal Epithelial Cancer, Gastrointestinal Tumors, Cancer of Gastrointestinal Tract Trial in Minneapolis

Recruiting
  • Gastrointestinal Epithelial Cancer
  • +10 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Aug 20, 2021

Guselkumab and Interleukin-17 Inhibitor Therapies in Psoriatic

Recruiting
  • Arthritis, Psoriatic
  • Buenos Aires, Argentina
  • +149 more
Aug 11, 2022

Type 1 Diabetes Trial in Le Kremlin Bicetre, Nimes, Paris (Dose D1 of interleukin-2, , Dose D2 of Interleukin-2)

Completed
  • Type 1 Diabetes
  • Dose D1 of interleukin-2
  • +3 more
  • Le Kremlin Bicetre, France
  • +5 more
Nov 10, 2020

Lung Cancer, Small Cell Lung Carcinoma, Non Small Cell Lung Cancer Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T Infusion)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • iC9.GD2.CAR.IL-15 T Infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Nov 16, 2022

COVID-19, Lymphocytopenia Trial in United Kingdom (Interleukin-7, Placebos)

Terminated
  • COVID-19
  • Lymphocytopenia
  • Birmingham, United Kingdom
  • +12 more
Mar 30, 2022

Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

Not yet recruiting
  • Breast Cancer
  • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
  • Ottawa, Ontario, Canada
  • +1 more
Jul 22, 2023

Advanced Ovarian Cancer, Malignant Melanoma Trial in Toronto (drug, procedure, biological)

Completed
  • Advanced Ovarian Cancer
  • Malignant Melanoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Aug 12, 2020

Allergic Contact Dermatitis Trial (Anakinra, Sodium Chloride 9mg/ml Injection)

Not yet recruiting
  • Allergic Contact Dermatitis
  • (no location specified)
Aug 9, 2022

Severe Sepsis With Septic Shock Trial in Nashville (Interleukin-7, Placebo)

Completed
Has Results
  • Severe Sepsis With Septic Shock
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jul 8, 2020

Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (drug, biological, other)

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 18, 2021

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Recruiting
  • Metastatic Melanoma
  • +5 more
  • Aldesleukin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 10, 2020